Cargando…
Proton pump inhibitors (PPIs) impact on tumour cell survival, metastatic potential and chemotherapy resistance, and affect expression of resistance-relevant miRNAs in esophageal cancer
BACKGROUND: Neoadjuvant treatment plays a crucial role in the therapy of advanced esophageal cancer. However, response to radiochemotherapy varies widely. Proton pump inhibitors (PPIs) have been demonstrated to impact on chemotherapy in a variety of other cancers. We analyzed the impact of PPI treat...
Autores principales: | Lindner, Kirsten, Borchardt, Christiane, Schöpp, Maren, Bürgers, Anja, Stock, Christian, Hussey, Damian J, Haier, Jörg, Hummel, Richard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4431491/ https://www.ncbi.nlm.nih.gov/pubmed/25175076 http://dx.doi.org/10.1186/s13046-014-0073-x |
Ejemplares similares
-
Complex Epigenetic Regulation of Chemotherapy Resistance and Biology in Esophageal Squamous Cell Carcinoma via MicroRNAs
por: Lindner, Kirsten, et al.
Publicado: (2018) -
Correction: Complex Epigenetic Regulation of Chemotherapy Resistance and Biology in Esophageal Squamous Cell Carcinoma via MicroRNAs. Int. J. Mol. Sci. 2018, 19, 499
por: Lindner, Kirsten, et al.
Publicado: (2019) -
Current status of acid pump antagonists (reversible PPIs).
por: Wurst, W., et al.
Publicado: (1996) -
Rebamipide with Proton Pump Inhibitors (PPIs) versus PPIs Alone for the Treatment of Endoscopic Submucosal Dissection-Induced Ulcers: A Meta-analysis
por: Liu, Junyuan, et al.
Publicado: (2020) -
Complex role of miR-130a-3p and miR-148a-3p balance on drug resistance and tumor biology in esophageal squamous cell carcinoma
por: Eichelmann, A. K., et al.
Publicado: (2018)